Address
Alexandria Real Estate Equities Inc
385 E Colorado Blvd
Suite 299
Pasadena, CA 91101
United States
Alexandria Real Estate Equities Inc
385 E. Colorado Blvd
Suite 299
Pasadena, CA 91101
United States
Alexandria Real Estate Equities Inc
385 E. Colorado Blvd
Suite 299
Pasadena, CA 91101
United States
Alexandria Real Estate Equities Inc
385 E. Colorado Blvd
Suite 299
Pasadena, CA 91101
United States
Alexandria Real Estate Equities Inc
385 E. Colorado Blvd
Suite 299
Pasadena, CA 91101
United States
Phone
Website
VCID: 30642
Profile
Corporate information
Official name
Alexandria Real Estate Equities Inc
Official name
Alexandria Real Estate Equities Inc
Investment activity status
Active investor
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Theraclone Sciences Inc |
United States | 1 Mar 2010 1 Sep 2011 |
Series B |
|
|
|
Metabolon Inc Provider of biomarker discovery and analysis |
United States | 7 Dec 2009 | Series C |
|
|
Cambrios Technologies Corp Developer of proprietary nanostructured electronic materials for the display industry |
United States | 1 Nov 2009 | Series D Initial investment. Round participant. Active |
|
|
|
BrainCells Inc A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. |
United States | 1 Apr 2008 | Series B Active |
|
|
|
Cerulean Pharma Inc |
United States | 1 Jan 2008 | Series B |
|
|
|
BioRelix Inc Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. |
United States | 4 Jun 2007 | Series A Follow-on investment. Round participant. Active |
|
|
|
Sirtris Pharmaceuticals Inc |
United States | 19 Apr 2006 | Series C Active |
|
|
|
Magen BioSciences Inc |
United States | N/A |
||
|
|
VLST Corp |
United States | N/A |
||
|
|
MAP Pharmaceuticals Inc Proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs. |
United States | N/A |
||
|
|
MacroGenics Inc Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. |
United States | N/A Active |
||
|
|
MiddleBrook Pharmaceuticals Inc A pharmaceutical company engages in the development and commercialization of anti-infective drug products. |
United States | N/A |
||
|
|
Concert Pharmaceuticals Inc A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. |
United States | N/A Active |
||
|
Nanosys Inc Nanotechnology-enabled systems |
United States | N/A Active |
||
|
|
Genocea Biosciences Inc |
United States | N/A |